ArticleFrontiers in immunology2025

CCL18: a potential immunosuppressive biomarker for prognosis in ABC diffuse large B-cell lymphoma.

Marta Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.